Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study. - Wikidata - wikimedia - TriplyDB

Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.

Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.

http://www.wikidata.org/entity/Q34317900

about

Tricyclic antidepressant pharmacology and therapeutic drug interactions updated SEP-225289 serotonin and dopamine transporter occupancy: a PET study Imaging the serotonin transporter during major depressive disorder and antidepressant treatment The development, past achievements, and future directions of brain PET Efficacy, safety, and tolerability of a triple reuptake inhibitor GSK372475 in the treatment of patients with major depressive disorder: two randomized, placebo- and active-controlled clinical trials Inhibition of autophagy suppresses sertraline-mediated primary ciliogenesis in retinal pigment epithelium cells Synthesis, isolation and purification of [(11)C]-choline Paradoxical anxiogenic response of juvenile mice to fluoxetine Modeling of PET data in CNS drug discovery and development.Molecular imaging for depressive disorders.Altered γ-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressants Chronic SSRI stimulation of astrocytic 5-HT2B receptors change multiple gene expressions/editings and metabolism of glutamate, glucose and glycogen: a potential paradigm shift.A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder.How psychotherapy changes the brain--the contribution of functional neuroimaging.Mind over PMDD: A Glimpse into the Process of Pharmacotherapy-Psychotherapy Combination Treatment A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?Changes in intensity of serotonin syndrome caused by adverse interaction between monoamine oxidase inhibitors and serotonin reuptake blockers Estimation of the optimal dosing regimen of escitalopram in dogs: A dose occupancy study with [11C]DASB Design and synthesis of 4-heteroaryl 1,2,3,4-tetrahydroisoquinolines as triple reuptake inhibitors.Preclinical and clinical pharmacology of DOV 216,303, a "triple" reuptake inhibitor.In vivo studies of the SERT-selective [18F]FPBM and VMAT2-selective [18F]AV-133 radiotracers in a rat model of Parkinson's disease.Escitalopram--translating molecular properties into clinical benefit: reviewing the evidence in major depression.ITI-007 demonstrates brain occupancy at serotonin 5-HT₂A and dopamine D₂ receptors and serotonin transporters using positron emission tomography in healthy volunteers.The serotonergic system in the neurobiology of depression: Relevance for novel antidepressants.Multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine--a quantitative EEG study in rats.Bupropion: pharmacology and therapeutic applications.Brain serotonin transporter binding in non-depressed patients with Parkinson's disease.The rapid recovery of 5-HT cell firing induced by the antidepressant vortioxetine involves 5-HT(3) receptor antagonism.Brain serotonin transporter occupancy by oral sibutramine dosed to steady state: a PET study using (11)C-DASB in healthy humans.Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): enhancing serotonin release by combining serotonin (5HT) transporter inhibition with actions at 5HT receptors (5HT1A, 5HT1B, 5HT1D, 5HT7 receptors).Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 2, pharmacological interactions in rodents suggest a role of serotonin-3 receptor antagonism.Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 1, a pharmacokinetic/pharmacodynamic comparison with paroxetine in healthy men.Anxiety is associated with reduced central serotonin transporter availability in unmedicated patients with unipolar major depression: a [11C]DASB PET study.The interaction of escitalopram and R-citalopram at the human serotonin transporter investigated in the mouse.Serotonin transporter occupancy in rats exposed to serotonin reuptake inhibitors in utero or via breast milk.Monoamine oxidase A inhibitor occupancy during treatment of major depressive episodes with moclobemide or St. John's wort: an [11C]-harmine PET study.[11C]MADAM Used as a Model for Understanding the Radiometabolism of Diphenyl Sulfide Radioligands for Positron Emission Tomography (PET).Disproportionate Reduction of Serotonin Transporter May Predict the Response and Adherence to Antidepressants in Patients with Major Depressive Disorder: A Positron Emission Tomography Study with 4-[18F]-ADAM.Exposure-outcome analysis in depressed patients treated with paroxetine using population pharmacokinetics.Serotonin transporter occupancy with TCAs and SSRIs: a PET study in patients with major depressive disorder.

P2860

Q24564967-11C00CF7-A399-4888-AAEE-D3E08D516C4C Q24631062-DF166EB5-E29E-43D6-982E-05543C5AD410 Q24683135-89347CE3-03E0-428F-B035-83C9989F5EEB Q27026331-080D6696-069F-4A84-B1B4-5ECAA2835A3F Q28252146-40E7E775-4B09-4D36-B7B1-D00205FC5055 Q28543400-02F9836D-6307-474F-AEAF-FFD268021793 Q28831129-F055A7BF-2E49-43C5-A91B-267663777605 Q30491364-F06DCE7B-B9BC-4C99-AFD0-3BB942089589 Q30623699-D8E6BE61-BD7C-47EB-BFEB-4F52CCCB135D Q30821361-69F1B722-E19A-4A36-8CCC-F16C606F9D4A Q30887852-70ADBF44-6208-4272-9FCE-628D351383B1 Q30906677-6ACFBC91-E9DE-4855-B1AD-15DB7157AAF1 Q30987882-CFA9B2D1-4714-48ED-96BE-DD39D8EE57E3 Q33235643-19CA0AA4-0B62-40D7-8823-40B47B13967D Q33654159-812FEB1A-C544-48CC-A626-F979B2F34CF3 Q33718185-FBC13010-CAF7-47AE-85D9-C0BC0FD010F0 Q33764320-D58CD38A-2090-422C-A34B-F46C9EEFD7D7 Q33828983-76048017-E71B-4420-B1D8-7EFF1C61D382 Q33889048-6F284132-D5EF-4EE8-84D9-A1FCE1CA12A5 Q33999301-36E4D023-D26B-4A7A-83ED-7E6B26EEFBB5 Q34018843-982184AA-288C-4C7C-AF31-6359F79070EF Q34072466-3C3B0449-91F4-469A-B2FC-E7B1BD3172BD Q34470362-297534B2-CC49-4540-893F-02B50332FBDE Q34497909-906F3108-9A84-4297-BE6C-3DC90068794D Q34559591-D6FA5B15-32F1-441C-B5A5-4CC085F78134 Q34569990-9F503AA8-37D0-4EEF-8085-A71E5884C3AF Q34619565-5A8DD59D-BFC4-495B-9E64-84868080A6C7 Q34644369-E063C6D3-3FED-484A-8002-417EBD3D627D Q34661571-EDA83AD3-0125-48DD-A24B-6138B66B9659 Q34669080-725AAEEC-0146-434A-9FCC-8115455DD7C2 Q34671692-7A2E6FFA-F51B-4B0F-9C03-8A5448E7277F Q34672117-91009B3D-E0A6-471D-A612-057BF2568D97 Q34749301-DF253DA4-9BEF-499D-B10C-87D57A1BEEA6 Q35137131-6A107714-8344-4E4D-ABBC-5894656C9461 Q35265670-62B96CEE-3A6A-41B6-8C56-5A2F898A886B Q35448551-ADA6B842-0A4B-4E42-91C4-23CB232480EF Q35772756-8959CF6F-2F84-4742-8C90-8581A464C36B Q35965853-38A28EB7-313C-4CD8-899D-4BA9CEF1F1F8 Q36079358-32EA338E-7CE3-419A-A899-30FCE9AD22B7 Q36132042-E1D6053F-6F7F-4888-9873-FC4C51B722CE

P2860

Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.

http://www.wikidata.org/entity/Q34317900

description

2004 nî lūn-bûn

@nan

2004 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Serotonin transporter occupanc ...... ron emission tomography study.

@ast

Serotonin transporter occupanc ...... ron emission tomography study.

@en

Serotonin transporter occupanc ...... ron emission tomography study.

@nl

type

label

Serotonin transporter occupanc ...... ron emission tomography study.

@ast

Serotonin transporter occupanc ...... ron emission tomography study.

@en

Serotonin transporter occupanc ...... ron emission tomography study.

@nl

prefLabel

Serotonin transporter occupanc ...... ron emission tomography study.

@ast

Serotonin transporter occupanc ...... ron emission tomography study.

@en

Serotonin transporter occupanc ...... ron emission tomography study.

@nl

P1433

Q34317900-412ACB15-0983-4D79-AE49-B6577D43F032

P1476

Q34317900-4BBE82AF-0DC3-445B-81AE-9DD514837131

P2093

Q34317900-23F2F850-F0EF-4BE5-8A1C-23BCF8A2B60E

Q34317900-4C9120C3-AE2B-4358-83AB-35AF7B413C0C

Q34317900-BA4F488B-9118-414D-9EB6-1BED78F320C4

Q34317900-BD3F53F3-6838-46B8-9ABB-CFA2618782D8

Q34317900-C3B9E8FB-E94B-40A4-9666-14CFBBBADA4C

Q34317900-D3044403-092B-4DE5-BCF0-E767B5A40710

Q34317900-DFC0EE27-2434-4893-B5E5-A9CF3E07D83C

Q34317900-FCBD34E6-49AD-46D0-A4F7-C8FA9F88A765

Q34317900-FF55B975-62AB-40F1-BB54-357FDB41F5B0

P304

Q34317900-862E7902-C353-44B8-BFC9-820CD4FB0FD3

P31

Q34317900-714E4306-2009-40BB-9549-0E19F1E2E305

P356

Q34317900-DD9BEBE9-253A-4652-BFAC-765FEE6FAF61

P407

Q34317900-7A925E51-C926-4314-812A-90960F3DD735

P433

Q34317900-8E020FB5-A47A-495F-8A67-A7FC8F7D566C

P478

Q34317900-4EF66D1A-60DD-4D7D-AAAC-945EBE56445B

P50

Q34317900-A187F440-EFFC-4B69-A18E-72F9D8C1166B

P577

Q34317900-52C67D2D-3079-4637-8CE2-5C50F5B0545C

P5875

Q34317900-3C074B28-DBA9-4C76-AC24-4DBD2DE7FD4F

P698

Q34317900-D57681D5-F179-4492-BDAE-8CC0C2F432A0

P921

Q34317900-569c9571-4819-4a3b-97d9-2267bf3b44dc

P356

APPI.AJP.161.5.826

P1433

American Journal of Psychiatry

P1476

Serotonin transporter occupanc ...... tron emission tomography study

@en

P2093

Alan A Wilson

http://www.w3.org/2001/XMLSchema#string

Andy Cheok

http://www.w3.org/2001/XMLSchema#string

Anna Carella

http://www.w3.org/2001/XMLSchema#string

Doug Hussey

http://www.w3.org/2001/XMLSchema#string

Edgar P Spencer

http://www.w3.org/2001/XMLSchema#string

Jeffrey H Meyer

http://www.w3.org/2001/XMLSchema#string

Nathalie Ginovart

http://www.w3.org/2001/XMLSchema#string

Sandra Sagrati

http://www.w3.org/2001/XMLSchema#string

William Z Potter

http://www.w3.org/2001/XMLSchema#string

P304

826-835

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1176/APPI.AJP.161.5.826

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

161

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8583114

http://www.w3.org/2001/XMLSchema#string

P698

15121647

http://www.w3.org/2001/XMLSchema#string

P921